Medicare is weighing the elimination of its breakthrough device payment pathway, a program designed to accelerate reimbursement access for novel medical technologies cleared by the FDA under the Breakthrough Device Designation. The pathway has served as a critical bridge between regulatory clearance and commercial viability, allowing device makers to receive Medicare payment while longer-term coverage determinations are finalized. Removing it would force manufacturers of newly cleared devices into standard Medicare coverage review processes, which are slower and less predictable. Companies relying on the pathway for near-term revenue visibility, particularly early-stage medtech firms, face the greatest exposure if the program is discontinued. The policy decision would reshape the commercial calculus for breakthrough-designated products and could dampen investment in high-risk device development where reimbursement certainty is a prerequisite for fundraising.
India's Expenditure Finance Committee has cleared a Rs 1.25 lakh crore outlay for India Semiconductor Mission 2.0, up 64 percent from ISM 1.0's Rs 76,000 crore. The proposal now goes to the Cabinet, as two chip plants begin commercial output and a third, CG Semi, is set to open July 4, 2026.
The Supreme Court blocked Trump from firing Federal Reserve board member Lisa Cook, preserving the Fed's independence from presidential removal power. A separate ruling the same day gave Trump broader authority to dismiss leaders of other independent federal agencies.
The US Supreme Court has blocked President Trump's attempt to fire Federal Reserve governor Lisa Cook, who faced unproven mortgage fraud allegations. The ruling preserves Fed independence for now and keeps a politically charged removal case alive in the courts.
The US Supreme Court, splitting along ideological lines, has allowed the Trump administration to end Temporary Protected Status for Haitian and Syrian immigrants.
